NEW2026 · Text us +1 272-529-4722
A non-stimulant option used to treat attention disorders.
Reviewed by:
Dr. Steve Malen, PharmD
Dr. Steven Blikstein, PharmD
Strength
How would you like to get this medication?
Choose a strength and quantity to continue.
Atomoxetine is a prescription medication used to treat attention-deficit hyperactivity disorder (ADHD) in children, adolescents, and adults. Unlike stimulant medications commonly used for ADHD, atomoxetine is a selective norepinephrine reuptake inhibitor (NRI) that helps improve focus, attention, and impulse control by boosting norepinephrine levels. It is not considered habit-forming and has a lower risk of misuse or dependence. Atomoxetine is available only with a prescription and should be taken exactly as directed by your healthcare provider.
Complete a health screening
A short questionnaire about your health history and current symptoms — takes about 2 minutes.
Provider reviews your answers
A licensed provider reviews your screening answers, typically within 24 hours.
Prescription fulfilled
If approved, your Rx is sent to Invictus Pharmacy and you're notified by text or email. Free nationwide shipping.
Important safety information
Strattera (atomoxetine) can interact with several medications and substances, which may alter its effectiveness or increase the risk of side effects. Because Strattera works by increasing norepinephrine levels in the brain—a neurotransmitter that also affects heart rate and blood pressure—certain combinations of drugs can amplify its stimulant-like cardiovascular effects.
Understanding these interactions is essential to using Strattera safely and getting the most out of treatment for ADHD or related conditions.
In all cases, open communication with a healthcare provider is the best safeguard against harmful drug interactions. Never start, stop, or adjust the dose of any medication without medical advice. Regular monitoring of blood pressure, heart rate, and mood during Strattera therapy helps ensure safe and effective treatment.
Atomoxetine is a prescription medication classified as a selective norepinephrine reuptake inhibitor (NRI). It is approved for the treatment of attention-deficit hyperactivity disorder (ADHD) and works by increasing norepinephrine levels in the brain. This neurotransmitter plays a key role in attention regulation, impulse control, and executive functioning.
Unlike stimulants, atomoxetine does not directly stimulate dopamine release in the brain’s reward pathways. Because of this, it carries a lower risk of abuse, misuse, or dependence and is not classified as a controlled substance. This makes it suitable for long-term ADHD management for those who can’t tolerate stimulants or have a history of substance sensitivity.
Note: This medication’s generic and brand-name formulations are used interchangeably throughout this article.
Strattera is the brand-name version of atomoxetine and is prescribed to treat ADHD in children, adolescents, and adults. It is typically taken once or twice daily and provides continuous symptom control throughout the day rather than the short, peak-based effects seen with stimulant medications.
Because Strattera is a non-stimulant, it may be preferred for patients who experience stimulant-related side effects such as insomnia, appetite suppression, increased anxiety, or mood swings.
While symptom improvement with Strattera may take several weeks to become noticeable, its steady mechanism of action allows for consistent therapeutic benefits without the highs and lows commonly associated with stimulant therapy.
Strattera is primarily indicated for the treatment of ADHD in both pediatric and adult populations. ADHD is a neurodevelopmental disorder characterized by symptoms of inattention, hyperactivity, and impulsivity. It helps patients improve attention spans, reduce impulsive behaviors, and control hyperactive tendencies.
Its use extends across a variety of age groups, including children 6 years and older and adults. For pediatric patients, Strattera provides an alternative when stimulant medications are not suitable due to contraindications or adverse reactions.
In adults, ADHD often presents with different challenges compared to children, and Strattera’s efficacy across life stages is valuable in comprehensive ADHD treatment plans.
Strattera’s distinct therapeutic pathway makes it a preferred option for patients who experience adverse effects from stimulant medications or for those with coexisting conditions where stimulants are not recommended.
Its long-term use requires consistent monitoring by healthcare professionals to ensure optimal therapeutic outcomes and manage any side effects that may arise.
Administration & Dosage
Strattera is administered orally as a capsule. It can be ingested with or without food, and it's typically taken once or twice daily, depending on your doctor's recommendations. It's essential to follow the dosing schedule your healthcare provider provides to achieve optimal results. Taking Strattera consistently at the same time each day aids in maintaining steady drug levels in your system.
The usual initial dose of Strattera is 40 mg per day. Depending on your response to the treatment, your doctor may increase the dosage. For individuals who do not show improvement at lower doses, the dose may be gradually increased to a maximum of 100 mg per day. Dosage adjustments are often based on a patient's age, weight, and symptom severity.
The best time to take Strattera is typically in the morning or early afternoon. By taking the medication at these times, you can avoid potential interference with your sleep patterns. It's recommended to take the medication at the same time each day. This consistency helps maintain a consistent drug concentration in your bloodstream, which can contribute to better symptom management.
It is generally not advisable to take Strattera at night, as it may disrupt your sleep. Since the medication can remain active in your system for several hours, taking it in the evening might lead to insomnia or restless sleep. However, if your doctor recommends a nighttime dosing schedule due to specific circumstances, it is important to follow their advice while closely monitoring your sleep patterns.
Aripiprazole is a prescription antipsychotic medication used to treat a range of mental health conditions, including schizophrenia, bipolar I disorder, major depressive disorder (as an add-on therapy), Tourette’s disorder, and irritability associated with autism spectrum disorder. It works by helping restore the balance of neurotransmitters in the brain, particularly dopamine and serotonin. Aripiprazole should be taken exactly as prescribed. Do not stop taking it suddenly, as this may cause withdrawal symptoms or a return of mental health symptoms.
Strattera works by increasing norepinephrine levels, a neurotransmitter associated with attention and impulse control. Its mechanism provides therapeutic effects that improve focus, control hyperactive behavior, and enhance the ability to organize activities.
Given its pharmacological profile, Strattera can be particularly useful in patients contraindicated for stimulant therapy or those who have not responded adequately to these interventions.
The mechanism of action of Strattera centers on its selective inhibition of norepinephrine reuptake, a key neurotransmitter involved in the regulation of attention, impulse control, and hyperactivity. Unlike stimulant medications, which primarily affect the dopamine pathways, Strattera offers a unique treatment paradigm by focusing on norepinephrine modulation.
Atomoxetine’s action is most prominent in the prefrontal cortex, a brain region heavily involved in executive function and attention regulation. By increasing norepinephrine levels in this region, Strattera enhances signal transmission, thereby improving cognitive control over attention and behavior.
This targeted action allows for symptom reduction in both the inattention and hyperactivity/impulsivity domains of ADHD.
Following administration, atomoxetine is well absorbed, with peak plasma concentrations typically achieved within 1-2 hours. The medication is metabolized in the liver, primarily via the cytochrome P450 2D6 pathway, leading to interindividual variation in metabolic rates.
Note that, due to this variability, Strattera requires individualized dosing adjustments to achieve optimal therapeutic efficacy while minimizing adverse effects.
Critical Dosing Note: Approximately 7% of Caucasians and a smaller percentage of other populations are CYP2D6 poor metabolizers, which can cause Strattera blood levels to rise up to 10× higher than normal, increasing the risk of severe side effects even at standard doses; warning signs include extreme insomnia, resting heart rate over 100 bpm, or severe nausea at low doses, and affected individuals may require significant dose reduction or genetic testing for confirmation.
Strattera is supplied as capsules for oral administration. The dosing regimen is largely contingent upon the patient’s weight and therapeutic needs, necessitating careful consideration by healthcare professionals.
Strattera can be administered with or without food, providing flexibility to accommodate patient preferences and minimize gastrointestinal side effects.
Many healthcare providers recommend administering Strattera in the morning or early afternoon to align with the natural circadian rhythm, enhancing daytime symptom control while minimizing the risk of sleep disturbances.
Patients must follow their healthcare provider’s dosing instructions to ensure optimal benefit and manage any potential side effects.
While the onset of therapeutic effects might not be immediate, many individuals begin to observe symptom improvement within a few weeks of consistent use, with maximum benefits sometimes taking up to 8 weeks. The medication’s half-life permits once-daily or twice-daily dosing, thereby maintaining consistent symptom control throughout the day.
The distinct non-stimulant property of Strattera also means it does not exacerbate anxiety or lead to the rebound effects commonly associated with stimulant medications.
While Strattera is generally well-tolerated, like all medications, it can cause a range of side effects—from mild discomfort to more serious health concerns.
The most frequently reported side effects of Strattera are mild to moderate and often improve as the body adjusts to the medication over time.
Although serious side effects are rare, they can occur and require immediate medical evaluation.
Regular check-ins with a healthcare provider, particularly during the early stages of therapy, can help ensure that the treatment remains safe, effective, and well-suited to the individual’s needs.
Strattera can interact with a range of medications and substances, potentially increasing side effect risks or altering therapeutic effectiveness. Understanding how Strattera interacts with other medications is vital to optimizing its efficacy and minimizing hazardous side effects.
Patients should always inform their healthcare provider about all prescription and over-the-counter medications, vitamins, and herbal supplements they are taking. This enables careful monitoring, dose adjustment, or substitution with safer alternatives where necessary.
If you miss a dose of Strattera, it's best to take it as soon as you remember, unless you're close to your next scheduled dose. In such cases, skip the missed dose and continue with your regular schedule. Doubling doses to make up for a missed dose is not recommended, as it may increase the risk of side effects. If you frequently forget to take your medication, consider setting reminders or alarms to help you maintain your dosing schedule.
Uses & Mechanism of Action
Strattera is primarily used for the management of Attention Deficit Hyperactivity Disorder (ADHD) in both children and adults. It helps enhance attention span while reducing impulsiveness and hyperactivity. This can lead to improved focus on tasks, better academic or work performance, and improved social interactions. Strattera is often prescribed for individuals who do not respond well to stimulant medications or for those who prefer a non-stimulant option.
Strattera works by selectively inhibiting the reuptake of norepinephrine, a neurotransmitter in the brain. This action increases the amount of norepinephrine available in the central nervous system, improving focus and attention. Unlike stimulant medications, Strattera's mechanism does not primarily affect dopamine. This contributes to its classification as a non-stimulant ADHD medication, offering an alternative to those who may not tolerate stimulants well.
Strattera is not classified as a stimulant. While stimulants are commonly used in the treatment of ADHD, they primarily affect dopamine levels. Strattera, known generically as atomoxetine, is a norepinephrine reuptake inhibitor. This distinction makes it a preferable option for certain individuals, particularly those with a history of substance abuse or those who experience adverse effects from stimulant medications.
Strattera is not classified as a controlled substance. Its non-stimulant nature and distinct mechanism of action reduce potential misuse or dependence risks, unlike many stimulant-based ADHD medications. This can add a layer of comfort for patients and healthcare providers concerned about medication misuse.
Side Effects & Safety
Common side effects associated with Strattera include stomach upset, nausea, fatigue, decreased appetite, dry mouth, and, in some cases, dizziness. These symptoms are often mild and may diminish as your body adjusts to the medication. It's important to monitor how you feel during the first few weeks of treatment and report any persistent or bothersome side effects to your healthcare provider.
Weight loss can occur as a side effect of Strattera, primarily due to decreased appetite. Monitoring weight changes is important, particularly in children and adolescents who are still growing. If significant weight loss is observed, it should be discussed with a healthcare provider. Adjustments to diet, meal scheduling, or medication dosage may be necessary to ensure that nutritional needs are being met.
While less common, some individuals might experience weight gain as a side effect of Strattera. This could be due to decreased physical activity or changes in metabolism. However, substantial weight gain is not a typical outcome with Strattera use. Regularly monitoring weight and discussing any significant changes with your healthcare provider can help address concerns about weight management.
Fatigue or drowsiness can be a side effect of Strattera. If you experience significant tiredness, particularly when you first start taking the medication, it's important to avoid activities that require full alertness, such as driving or operating heavy machinery. Over time, your body may adjust, and these feelings may decrease. If sleepiness persists, consulting your healthcare provider can help determine whether an adjustment to your dosage or schedule is needed.
Interactions & Contraindications
Combining Strattera with alcohol is generally not recommended. Alcohol can increase some side effects of Strattera, such as dizziness and impaired judgment, potentially leading to unsafe situations. It's advisable to limit or avoid alcohol consumption while taking this medication to minimize risks.
There are no known severe interactions between valsartan, a commonly used high blood pressure medication, and Strattera. However, it is always crucial to discuss all medications and supplements you are taking with your healthcare provider to ensure safety and address any potential interactions that could affect your treatment or overall health.
Strattera should not be used by individuals with a known hypersensitivity to atomoxetine or any of its components. It is also contraindicated in patients with narrow-angle glaucoma and those who have used Monoamine Oxidase Inhibitors (MAOIs) in the past 14 days, due to the risk of increased blood pressure. Those with severe heart conditions should also avoid this medication. A detailed discussion with your healthcare provider can help identify any personal risk factors.
The safety of Strattera during pregnancy has not been conclusively established. If you are pregnant or planning to become pregnant, it is essential to discuss the potential risks and benefits of continuing Strattera with your healthcare provider. They can help you weigh the risks and determine the best course of action for your specific situation.
Generic & Alternatives
Strattera is available as a generic medication under the name atomoxetine. The availability of a generic version makes this treatment option more accessible and affordable for many patients compared to the brand-name product. Generic versions contain the same active ingredients and work in the same way as their brand-name counterparts.
Strattera and Adderall are not the same. Adderall is a stimulant medication that contains amphetamine and dextroamphetamine, which primarily affect dopamine levels in the brain. Strattera, on the other hand, is a non-stimulant that works on norepinephrine. Each medication has its own benefits and potential side effects, and the choice between them should be made based on individual needs and medical history, often in consultation with a healthcare provider.
Substituting Strattera with another ADHD medication is possible, as there are numerous options available, both stimulant and non-stimulant. The decision to switch medications should be guided by a healthcare provider, who will consider factors such as symptom severity, any existing medical conditions, potential side effects, and personal preferences.
As of now, Strattera has not been discontinued and remains available in both brand and generic forms. Availability can vary by location and pharmacy, so it's advisable to check with local pharmacies to confirm supply status if you have difficulty obtaining the medication.
The effects of Strattera may take several weeks to become fully apparent. While some individuals may notice improvements in focus and behavior within a week, others may require additional time for the full therapeutic benefits to manifest. Patience and regular follow-ups with your healthcare provider are key during the initial treatment phase to assess response and make any necessary adjustments.
Mood changes, including feelings of depression, can occur with Strattera. Monitoring your mental health closely while on the medication is crucial. If you or those around you notice significant mood changes or if depressive symptoms arise, contact your healthcare provider to discuss potential adjustments or additional support. It's important to address mental health changes promptly to ensure optimal treatment outcomes.
Strattera can interact with various medications, including certain antidepressants and asthma medications. These interactions may impact the effectiveness of the medications or increase the risk of side effects. It's crucial to provide your healthcare provider with a comprehensive list of all medications you are taking, so they can make informed decisions about your treatment plan.
The cost of Strattera without insurance can vary widely, depending on the pharmacy, dosage, and location. Prices can vary, so it's a good idea to compare prices across pharmacies or inquire about discount programs and savings cards that could help reduce costs. Some online resources also offer price-comparison tools to help you find the most cost-effective option.
